Marvin Gatz
Pulmonary Disease · Fair Oaks, CANPI 1982627824
Payments from drug & device makers
Across 155 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$585
- Boehringer Ingelheim$358
- Genentech USA, Inc.$205
- AbbVie$204
- AstraZeneca$152
- Mylan Specialty L.p.$130
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,62297%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 35 | $585 |
| Boehringer Ingelheim | 17 | $358 |
| Genentech USA, Inc. | 4 | $205 |
| AbbVie | 14 | $204 |
| AstraZeneca(2 entities) | 8 | $152 |
| Mylan Specialty L.p. | 8 | $130 |
| Sunovion Pharmaceuticals Inc. | 13 | $103 |
| Grifols USA, LLC | 5 | $102 |
| Electromed, Inc. | 12 | $100 |
| Shire North American Group Inc | 4 | $89 |
| Insmed, Inc. | 1 | $75 |
| Merck | 5 | $72 |
| Tetraphase Pharmaceuticals, Inc. | 3 | $60 |
| Optinose US, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Kaleo, Inc. | 2 | $43 |
| Bayer | 2 | $41 |
| Advanced Respiratory, Inc | 3 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Philips North America LLC | 2 | $35 |
| Circassia Inc. | 2 | $32 |
| Harmony Biosciences LLC | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| United Therapeutics Corporation | 1 | $19 |
| Vyera Pharmaceuticals, LLC | 1 | $19 |
| Covis Pharma GmbH | 1 | $19 |
| Pfizer | 1 | $18 |
| Gilead | 1 | $14 |
| Fisher & Paykel Healthcare Inc | 1 | $11 |
How this compares
$2,697 in reported general payments places this provider in the 55th percentile of 1,261 pulmonary disease providers in California.
Other pulmonary disease in Fair Oaks
- Toby MaherLos Angeles$27.6M
- David PhamWestminster$5.9M
- Andrew WachtelLos Angeles$5.9M
- Aaron WeinbergIrvine$5.1M
- Michael RothLos Angeles$4.5M
- Namita SoodSacramento$3.7M
- Edward FedermanSan Diego$3.6M
- Sanjay VadgamaSherman Oaks$3.3M
- Rajan SaggarLos Angeles$3.3M
- Samuel LouieSacramento$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.